Abstract: The invention relates to cloning of the gene for the toxoplasma GP28.5 antigen. It also encompasses purified GP28.5 antigen preparations and antigenic polypeptides derived from said antigen, and their applications.
Type:
Grant
Filed:
June 5, 1998
Date of Patent:
May 21, 2002
Inventors:
Marie-France Cesbron, Corinne Mercier, André Capron, André Tartar, Pierrette Maes
Abstract: Disclosed herein is a device for storing and/or delivering an effective amount of biological or pharmaceutical material to an animal comprising a tube disposed to contain said biological or pharmaceutical material and sealed at its ends and adapted to provide an opening through which the biological or pharmaceutical material exits and is administered to an intended site of the animal.
Type:
Grant
Filed:
September 9, 1993
Date of Patent:
May 14, 2002
Inventors:
George P. Shibley, Karen K. Brown, Leszek J. Choromanski, Sharon A. Bryant
Abstract: The invention relates to a polypeptide capable of reacting specifically with an anti-Toxoplasma gondii P30 protein antibody, and comprising a peptide sequence, in which any succession of 6 contiguous amino acids exhibits at most 67 % homology with the peptide sequence of said P30 protein, identified by SEQ ID No.1, or comprising a sequence derived from said peptide sequence, and the applications of this polypeptide especially for detecting a Toxoplasma gondii infection, in a biological sample.
Abstract: The present invention relates to the identification of toxoplasma gondii antigens and the preparation thereof by genetic engineering. A cDNA expression gene bank of this parasite was prepared. Recombinant clones which are of diagnostic interest were identified using a high-titer rabbit anti-Toxoplasma gondii serum, and isolated.
Type:
Grant
Filed:
December 16, 1999
Date of Patent:
December 4, 2001
Assignee:
Dade Behring Marburg GmbH
Inventors:
Stefan Knapp, Robert Ziegelmaier, Hans Küpper